Pharmaceuticals News and Research

RSS

GlaxoSmithKline opens new facility in Philadelphia's Navy Yard Corporate Center

GlaxoSmithKline officially opened its new double LEED® platinum certified facility in Philadelphia's Navy Yard Corporate Center today, ushering in a new era of how people work in Philadelphia.

8 Apr 2013

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).

8 Apr 2013

GenSight Biologics announces closing of €32 million Series A financing

GenSight Biologics, a biopharmaceutical company focused on the development of ophthalmic therapeutics using gene therapy, announced today the closing of a €32 million Series A financing.

8 Apr 2013

FDA grants priority review for Bayer HealthCare's riociguat for treatment of CTEPH

Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.

8 Apr 2013

Berg to present new findings on cancer treatment, Interrogative Biology Platform at AACR meeting

Berg - a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach - announced today that it will be presenting four abstracts at the AACR Annual Meeting 2013, in Washington, D.C.

8 Apr 2013

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase inhibitor in development for rheumatoid arthritis.

6 Apr 2013

Dual challenges of Medical Education groups

The regulatory and financial environment has made it challenging for Medical Education groups to accomplish their principal goal of educating healthcare practitioners on the safe and effective use of new therapies.

6 Apr 2013

First Korean/U.S. workshop on drug regulation and marketing

Getting more and better drugs to market for patients was the ultimate goal of the University of Maryland School of Pharmacy's first Korean/U.S. workshop on drug regulation and marketing from March 18 to 22.

6 Apr 2013

Arena Pharmaceuticals kicks off APD334 Phase 1 clinical trial for treatment of autoimmune diseases

Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.

6 Apr 2013

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.

6 Apr 2013

SiDMAP announces publication of Isotopolome Wide Association Study in FASEB Journal

SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists at the University Of Utah School Of Medicine.

6 Apr 2013

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

A technology being developed at Oak Ridge National Laboratory promises to provide clear images of the brains of children, the elderly and people with Parkinson's and other diseases without the use of uncomfortable or intrusive restraints.

5 Apr 2013

Johns Hopkins scientist awarded Ho-Am prize for discovery of myostatin

South Korea's Ho-Am Foundation announced that Johns Hopkins researcher Se-Jin Lee, M.D., Ph.D., has won this year's Ho-Am Prize in Medicine.

5 Apr 2013

Non-invasive gut health testing breakthrough

Health and functional claims made for foods such as probiotics still need to prove their effectiveness ― an important part of the answer rests in our small intestines and their role in digestion, and immunity.

5 Apr 2013

One cohort of Phase 2 NSCLC study fails to meet primary endpoint, Merrimack says

Merrimack Pharmaceuticals, Inc. today announced that one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint. The cohort evaluated MM-121 in combination with erlotinib to treat patients with NSCLC whose disease progressed on an anti-EGFR tyrosine kinase inhibitor (EGFR-TKI).

5 Apr 2013

Agios, Foundation Medicine announce diagnostic partnership for cancer metabolism programs

Foundation Medicine, Inc., and Agios Pharmaceuticals, Inc., today announced a multi-year diagnostic partnership for Agios' lead programs in cancer metabolism.

4 Apr 2013

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Illumina, Inc. today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors.

From Illumina, Inc. 4 Apr 2013

ACE Group introduces new insurance for life science companies in Continental Europe

ACE Group today announced the launch of a new insurance proposition covering global life science risks for companies in Continental Europe as part of its strategy to further build its casualty offering for businesses in the region.

4 Apr 2013

Phenylbutazone in horsemeat detected by Thermo Fisher Scientific test

Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as “bute,” is a potent painkiller banned in any horsemeat intended for human consumption.

From Thermo Fisher Scientific Inc. 4 Apr 2013

Reuters examines implications of India's Novartis patent ruling for big pharma

Reuters examines the implications of India's Supreme Court ruling to reject drug maker Novartis's request for a new patent on an updated version of the cancer treatment Glivec on the pharmaceutical industry in India and across the developing world.

4 Apr 2013

Pharmaceuticals News and Research

GlaxoSmithKline opens new facility in Philadelphia's Navy Yard Corporate Center

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

GenSight Biologics announces closing of €32 million Series A financing

FDA grants priority review for Bayer HealthCare's riociguat for treatment of CTEPH

Berg to present new findings on cancer treatment, Interrogative Biology Platform at AACR meeting

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

Dual challenges of Medical Education groups

First Korean/U.S. workshop on drug regulation and marketing

Arena Pharmaceuticals kicks off APD334 Phase 1 clinical trial for treatment of autoimmune diseases

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

SiDMAP announces publication of Isotopolome Wide Association Study in FASEB Journal

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

Johns Hopkins scientist awarded Ho-Am prize for discovery of myostatin

Non-invasive gut health testing breakthrough

One cohort of Phase 2 NSCLC study fails to meet primary endpoint, Merrimack says

Agios, Foundation Medicine announce diagnostic partnership for cancer metabolism programs

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

ACE Group introduces new insurance for life science companies in Continental Europe

Phenylbutazone in horsemeat detected by Thermo Fisher Scientific test

Reuters examines implications of India's Novartis patent ruling for big pharma

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence